Understanding Advanced RCC: Epidemiology, Presentation, and Risk Stratification
Panelists discuss advanced renal cell carcinoma (RCC), including its epidemiology, typical disease presentation, and the common patient profile in terms of age, gender, and family history, while also addressing the risk stratification for advanced RCC, highlighting the differences between favorable and poor/intermediate risk categories.
Now Viewing
EP: 1.Understanding Advanced RCC: Epidemiology, Presentation, and Risk Stratification
EP: 2.James’ Journey with Clear Cell RCC: Diagnosis, Early Challenges, and His Treatment Journey
EP: 3.The Role of the Multidisciplinary Care Team in RCC
EP: 4.Exploring Standards of Care and Treatment Goals in Advanced Clear Cell RCC
EP: 5.Selecting the Right RCC Treatment Plan: Shared Decision-Making and Expert Advice
EP: 6.Key Clinical Trial Data and Insights in Advanced Clear Cell RCC
EP: 7.Proactively Managing Toxicities in RCC IO/TKI Combinations: Insights and Recommendations
EP: 8.Frontline Treatment Strategies in Non–Clear Cell RCC: Emerging Data and Trials
EP: 9.Enhancing Supportive Care and Quality of Life for RCC Patients
EP: 10.Improving the RCC Patient Journey and Future Therapeutic Directions
EP: 11.Clinicians Consider Identification, Management of RCC Through the Patient’s Eyes
Video content above is prompted by the following:
Please provide a brief overview of advanced RCC, including epidemiology and typical disease presentation.
- Who is a typical patient? (age, gender, family history, etc. )?
- Please comment on the risk stratification for patients with advanced RCC (favorable vs poor/intermediate).
Recent Videos
